Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy
Launched by CENTRE HOSPITALIER UNIVERSITAIRE, AMIENS · May 5, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the risks of blood clots in hospitalized patients with COVID-19, particularly those suffering from severe pneumonia. Researchers want to learn more about how the body's response to infection can affect blood clotting and inflammation. They will collect blood samples from patients at Amiens Hospital to check various factors related to blood clotting and inflammation every week. Additionally, they will perform ultrasounds to check for blood clots in the veins.
To participate in this trial, patients must be 18 years or older and currently hospitalized at Amiens Hospital due to a COVID-19 infection. During the study, participants can expect to have their blood tested regularly and undergo ultrasound examinations to help doctors understand the connection between COVID-19, inflammation, and blood clotting. This information could be vital in improving treatment for patients with COVID-19 in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients hospitalized in Amiens Hospital with COVID-19 infection
- Exclusion Criteria:
- • patients\< 18 years
About Centre Hospitalier Universitaire, Amiens
The Centre Hospitalier Universitaire (CHU) Amiens is a leading academic medical center in France dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, CHU Amiens integrates patient care, education, and research to enhance treatment outcomes and improve patient quality of life. The institution is committed to ethical standards and regulatory compliance in its clinical research endeavors, aiming to contribute significantly to the medical community and the development of new therapeutic approaches. By fostering partnerships with various stakeholders, CHU Amiens strives to translate scientific discoveries into practical applications that benefit patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amiens, , France
Amiens, , France
Patients applied
Trial Officials
Michel Slama, Pr
Principal Investigator
CHU Amiens
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials